FPH Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Fisher & Paykel Healthcare Corporation Ltd - Alpha Spread
F

Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH

Watchlist Manager
Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH
Watchlist
Price: 35.37 AUD -0.81% Market Closed
Market Cap: 20.7B AUD
Have any thoughts about
Fisher & Paykel Healthcare Corporation Ltd?
Write Note

Wall Street
Price Targets

FPH Price Targets Summary
Fisher & Paykel Healthcare Corporation Ltd

Wall Street analysts forecast FPH stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FPH is 28.95 AUD with a low forecast of 23.7 AUD and a high forecast of 37 AUD.

Lowest
Price Target
23.7 AUD
33% Downside
Average
Price Target
28.95 AUD
18% Downside
Highest
Price Target
37 AUD
5% Upside
Fisher & Paykel Healthcare Corporation Ltd Competitors:
Price Targets
PRN
Profound Medical Corp
55% Upside
QLINEA
Q linea AB
83% Upside
688161
Shandong Weigao Orthopaedic Device Co Ltd
208% Upside
SEDANA
Sedana Medical AB (publ)
89% Upside
287410
Jeisys Medical Inc
14% Upside
HOLX
Hologic Inc
11% Upside
ZIMV
ZimVie Inc
26% Upside
STIL
Stille AB
22% Upside

Revenue
Forecast

Revenue Estimate
Fisher & Paykel Healthcare Corporation Ltd

For the last 8 years the compound annual growth rate for Fisher & Paykel Healthcare Corporation Ltd's revenue is 10%. The projected CAGR for the next 3 years is 12%.

10%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Fisher & Paykel Healthcare Corporation Ltd

For the last 8 years the compound annual growth rate for Fisher & Paykel Healthcare Corporation Ltd's operating income is 7%. The projected CAGR for the next 3 years is 24%.

7%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Fisher & Paykel Healthcare Corporation Ltd

For the last 8 years the compound annual growth rate for Fisher & Paykel Healthcare Corporation Ltd's net income is -1%. The projected CAGR for the next 3 years is 55%.

-1%
Past Growth
55%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FPH's stock price target?
Price Target
28.95 AUD

According to Wall Street analysts, the average 1-year price target for FPH is 28.95 AUD with a low forecast of 23.7 AUD and a high forecast of 37 AUD.

What is Fisher & Paykel Healthcare Corporation Ltd's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Fisher & Paykel Healthcare Corporation Ltd's revenue is 10%. The projected CAGR for the next 3 years is 12%.

What is Fisher & Paykel Healthcare Corporation Ltd's Operating Income forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for Fisher & Paykel Healthcare Corporation Ltd's operating income is 7%. The projected CAGR for the next 3 years is 24%.

What is Fisher & Paykel Healthcare Corporation Ltd's Net Income forecast?
Projected CAGR
55%

For the last 8 years the compound annual growth rate for Fisher & Paykel Healthcare Corporation Ltd's net income is -1%. The projected CAGR for the next 3 years is 55%.

Back to Top